Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Glucocorticoid use and factors associated with variability in this use in the Systemic Lupus International Collaborating Clinics Inception Cohort.

Little J, Parker B, Lunt M, Hanly JG, Urowitz MB, Clarke AE, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Merrill JT, Buyon J, Isenberg DA, Rahman A, Ginzler EM, Petri M, Dooley MA, Fortin P, Gladman DD, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Mackay M, Alarcón GS, Manzi S, Nived O, Jönsen A, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Sam Lim S, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Sanchez-Guerrero J, Bruce IN.

Rheumatology (Oxford). 2018 Jan 18. doi: 10.1093/rheumatology/kex444. [Epub ahead of print]

PMID:
29361147
2.

Effects of Psychiatric Comorbidity in Immune-Mediated Inflammatory Disease: Protocol for a Prospective Study.

Marrie RA, Graff L, Walker JR, Fisk JD, Patten SB, Hitchon CA, Lix LM, Bolton J, Sareen J, Katz A, Berrigan LI, Marriott JJ, Singer A, El-Gabalawy R, Peschken CA, Zarychanski R, Bernstein CN.

JMIR Res Protoc. 2018 Jan 17;7(1):e15. doi: 10.2196/resprot.8794.

3.

Cerebrovascular Events in Systemic Lupus Erythematosus.

Hanly JG, Li Q, Su L, Urowitz MB, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Clarke AE, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Fortin P, Gladman DD, Bruce IN, Petri M, Ginzler EM, Dooley MA, Steinsson K, Ramsey-Goldman R, Zoma AA, Manzi S, Nived O, Jonsen A, Khamashta MA, Alarcón GS, Chatham W, van Vollenhoven RF, Aranow C, Mackay M, Ruiz-Irastorza G, Ramos-Casals M, Lim SS, Inanc M, Kalunian KC, Jacobsen S, Peschken CA, Kamen DL, Askanase A, Theriault C, Farewell V.

Arthritis Care Res (Hoboken). 2018 Jan 5. doi: 10.1002/acr.23509. [Epub ahead of print]

PMID:
29316357
4.

Economic evaluation of lupus nephritis in the Systemic Lupus International Collaborating Clinics inception cohort using a multistate model approach.

Barber MRW, Hanly JG, Su L, Urowitz MB, Pierre YS, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, Fortin PR, Gladman DD, Sanchez-Guerrero J, Ramsey-Goldman R, Khamashta MA, Aranow C, Mackay M, Alarcón GS, Manzi S, Nived O, Jönsen A, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Sam Lim S, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Theriault C, Farewell V, Clarke AE.

Arthritis Care Res (Hoboken). 2017 Nov 28. doi: 10.1002/acr.23480. [Epub ahead of print]

PMID:
29193883
5.

Markedly increased incidence of critical illness in adults with Type 1 diabetes.

Marrie RA, Sellers EAC, Chen H, Fransoo R, Bernstein CN, Hitchon CA, Peschken CA, Garland A.

Diabet Med. 2017 Oct;34(10):1414-1420. doi: 10.1111/dme.13404. Epub 2017 Jul 12.

PMID:
28626956
6.

Hospitalization is associated with subsequent disability in multiple sclerosis.

Garland A, Metz LM, Bernstein CN, Peschken CA, Hitchon CA, Marrie RA.

Mult Scler Relat Disord. 2017 May;14:23-28. doi: 10.1016/j.msard.2017.03.009. Epub 2017 Mar 24.

7.

Health care utilisation before and after intensive care unit admission in rheumatoid arthritis.

Marrie RA, Hitchon CA, Peschken CA, Chen H, Bernstein CN, Garland A.

Clin Exp Rheumatol. 2017 Nov-Dec;35(6):975-982. Epub 2017 Jun 5.

PMID:
28598781
8.

Increased Incidence of Critical Illness in Psoriasis.

Marrie RA, Bernstein CN, Peschken CA, Hitchon CA, Chen H, Garland A.

J Cutan Med Surg. 2017 Sep/Oct;21(5):395-400. doi: 10.1177/1203475417712497. Epub 2017 Jun 6.

PMID:
28587481
9.

The prevalence and determinants of anti-DFS70 autoantibodies in an international inception cohort of systemic lupus erythematosus patients.

Choi MY, Clarke AE, St Pierre Y, Hanly JG, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, Dooley MA, Fortin P, Gladman DD, Sanchez-Guerrero J, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Alarcón GS, Manzi S, Nived O, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim SS, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Buyon J, Mahler M, Fritzler MJ.

Lupus. 2017 Sep;26(10):1051-1059. doi: 10.1177/0961203317692437. Epub 2017 Feb 23.

PMID:
28420054
10.

Systematic Review and Meta-analysis of Interventions for Depression and Anxiety in Persons With Rheumatoid Arthritis.

Fiest KM, Hitchon CA, Bernstein CN, Peschken CA, Walker JR, Graff LA, Zarychanski R, Abou-Setta A, Patten SB, Sareen J, Bolton J, Marrie RA; CIHR Team “Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease”.

J Clin Rheumatol. 2017 Dec;23(8):425-434. doi: 10.1097/RHU.0000000000000489.

11.

Screening Tools for Anxiety in People with Multiple Sclerosis: A Systematic Review.

Litster B, Fiest KM, Patten SB, Fisk JD, Walker JR, Graff LA, Bolton JM, Sareen J, Marriott JJ, Berrigan LI, Bernstein CN, Zarychanski R, Singer A, Hitchon CA, Peschken CA, Marrie RA; CIHR Team “Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease”.

Int J MS Care. 2016 Nov-Dec;18(6):273-281. doi: 10.7224/1537-2073.2016-004.

12.

Systematic review of interventions for depression and anxiety in persons with inflammatory bowel disease.

Fiest KM, Bernstein CN, Walker JR, Graff LA, Hitchon CA, Peschken CA, Zarychanski R, Abou-Setta A, Patten SB, Sareen J, Bolton J, Singer A, Marrie RA; CIHR Team “Defining the burden and managing the effects of psychiatric comorbidity in chronic immunoinflammatory disease”.

BMC Res Notes. 2016 Aug 12;9(1):404. doi: 10.1186/s13104-016-2204-2. Review.

13.

Severe Sensory Neuronopathy in Primary Sjögren Syndrome Resulting in Charcot Arthropathy.

Nguyen M, Peschken CA.

J Rheumatol. 2016 Jul;43(7):1449-51. doi: 10.3899/jrheum.160137. No abstract available.

PMID:
27371653
14.

Inflammatory Arthritis Prevalence and Health Services Use in the First Nations and Non-First Nations Populations of Alberta, Canada.

Barnabe C, Jones CA, Bernatsky S, Peschken CA, Voaklander D, Homik J, Crowshoe LF, Esdaile JM, El-Gabalawy H, Hemmelgarn B.

Arthritis Care Res (Hoboken). 2017 Apr;69(4):467-474. doi: 10.1002/acr.22959. Epub 2017 Mar 9.

PMID:
27333120
15.

Development of the Lupus Interactive Navigator as an Empowering Web-Based eHealth Tool to Facilitate Lupus Management: Users Perspectives on Usability and Acceptability.

Neville C, Da Costa D, Rochon M, Peschken CA, Pineau CA, Bernatsky S, Keeling S, Avina-Zubieta A, Lye E, Eng D, Fortin PR.

JMIR Res Protoc. 2016 May 30;5(2):e44. doi: 10.2196/resprot.4219.

16.

Influence of Education on Disease Activity and Damage in Systemic Lupus Erythematosus: Data From the 1000 Canadian Faces of Lupus.

George A, Wong-Pak A, Peschken CA, Silverman E, Pineau C, Smith CD, Arbillaga H, Zummer M, Bernatsky S, Hudson M, Hitchon C, Fortin PR, Nevskaya T, Pope JE; 1000 Canadian Faces of Lupus Investigators.

Arthritis Care Res (Hoboken). 2017 Jan;69(1):124-132. doi: 10.1002/acr.22922. Epub 2016 Nov 21. Erratum in: Arthritis Care Res (Hoboken). 2017 Mar;69(3):458.

17.

A Longitudinal Analysis of Outcomes of Lupus Nephritis in an International Inception Cohort Using a Multistate Model Approach.

Hanly JG, Su L, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Clarke AE, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, Dooley MA, Fortin P, Gladman DD, Sanchez-Guerrero J, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Alarcón GS, Fessler BJ, Manzi S, Nived O, Sturfelt GK, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim SS, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Theriault C, Farewell V.

Arthritis Rheumatol. 2016 Aug;68(8):1932-44. doi: 10.1002/art.39674.

18.

A Population-based Study of Intensive Care Unit Admissions in Rheumatoid Arthritis.

Peschken CA, Hitchon CA, Garland A, Bernstein CN, Chen H, Fransoo R, Marrie RA.

J Rheumatol. 2016 Jan;43(1):26-33. doi: 10.3899/jrheum.150312. Epub 2015 Dec 1.

19.

The frequency and outcome of lupus nephritis: results from an international inception cohort study.

Hanly JG, O'Keeffe AG, Su L, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Clarke AE, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Fortin P, Gladman DD, Sanchez-Guerrero J, Petri M, Bruce IN, Dooley MA, Ramsey-Goldman R, Aranow C, Alarcón GS, Fessler BJ, Steinsson K, Nived O, Sturfelt GK, Manzi S, Khamashta MA, van Vollenhoven RF, Zoma AA, Ramos-Casals M, Ruiz-Irastorza G, Lim SS, Stoll T, Inanc M, Kalunian KC, Kamen DL, Maddison P, Peschken CA, Jacobsen S, Askanase A, Theriault C, Thompson K, Farewell V.

Rheumatology (Oxford). 2016 Feb;55(2):252-62. doi: 10.1093/rheumatology/kev311. Epub 2015 Sep 5.

20.

Health care utilization before and after intensive care unit admission in multiple sclerosis.

Marrie RA, Bernstein CN, Peschken CA, Hitchon CA, Chen H, Fransoo R, Garland A.

Mult Scler Relat Disord. 2015 Jul;4(4):296-303. doi: 10.1016/j.msard.2015.05.010. Epub 2015 May 30.

21.

Predictors of ICU Admission and Outcomes 1 Year Post-Admission in Persons with IBD: A Population-based Study.

Bernstein CN, Garland A, Peschken CA, Hitchon CA, Chen H, Fransoo R, Marrie RA.

Inflamm Bowel Dis. 2015 Jun;21(6):1341-7. doi: 10.1097/MIB.0000000000000363.

22.

Mood Disorders in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.

Hanly JG, Su L, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Clarke AE, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, Dooley MA, Fortin P, Gladman DD, Sanchez-Guerrero J, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Alarcón GS, Fessler BJ, Manzi S, Nived O, Sturfelt GK, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim SS, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Theriault C, Thompson K, Farewell V.

Arthritis Rheumatol. 2015 Jul;67(7):1837-47. doi: 10.1002/art.39111.

23.

Imbalance of prevalence and specialty care for osteoarthritis for first nations people in Alberta, Canada.

Barnabe C, Hemmelgarn B, Jones CA, Peschken CA, Voaklander D, Joseph L, Bernatsky S, Esdaile JM, Marshall DA.

J Rheumatol. 2015 Feb;42(2):323-8. doi: 10.3899/jrheum.140551. Epub 2014 Nov 29.

PMID:
25433531
24.

Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort.

Bruce IN, O'Keeffe AG, Farewell V, Hanly JG, Manzi S, Su L, Gladman DD, Bae SC, Sanchez-Guerrero J, Romero-Diaz J, Gordon C, Wallace DJ, Clarke AE, Bernatsky S, Ginzler EM, Isenberg DA, Rahman A, Merrill JT, Alarcón GS, Fessler BJ, Fortin PR, Petri M, Steinsson K, Dooley MA, Khamashta MA, Ramsey-Goldman R, Zoma AA, Sturfelt GK, Nived O, Aranow C, Mackay M, Ramos-Casals M, van Vollenhoven RF, Kalunian KC, Ruiz-Irastorza G, Lim S, Kamen DL, Peschken CA, Inanc M, Urowitz MB.

Ann Rheum Dis. 2015 Sep;74(9):1706-13. doi: 10.1136/annrheumdis-2013-205171. Epub 2014 May 16.

25.

Association of health-related quality of life in childhood-onset systemic lupus erythematosus with ethnicity: results from a multiethnic multicenter Canadian cohort.

Levy DM, Peschken CA, Tucker LB, Chédeville G, Huber AM, Pope JE; Canadian Network for Improved Outcomes in SLE (CaNIOS) 1000 Faces Investigators, Silverman ED.

Arthritis Care Res (Hoboken). 2014 Dec;66(12):1767-74. doi: 10.1002/acr.22363.

26.

Intensive care unit admission in multiple sclerosis: increased incidence and increased mortality.

Marrie RA, Bernstein CN, Peschken CA, Hitchon CA, Chen H, Fransoo R, Garland A.

Neurology. 2014 Jun 10;82(23):2112-9. doi: 10.1212/WNL.0000000000000495. Epub 2014 May 7.

27.

Increased incidence of critical illness among patients with inflammatory bowel disease: a population-based study.

Marrie RA, Garland A, Peschken CA, Hitchon CA, Chen H, Fransoo R, Bernstein CN.

Clin Gastroenterol Hepatol. 2014 Dec;12(12):2063-70.e1-4. doi: 10.1016/j.cgh.2014.03.033. Epub 2014 Apr 12.

PMID:
24726908
28.

Impact of early disease factors on metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort.

Parker B, Urowitz MB, Gladman DD, Lunt M, Donn R, Bae SC, Sanchez-Guerrero J, Romero-Diaz J, Gordon C, Wallace DJ, Clarke AE, Bernatsky S, Ginzler EM, Isenberg DA, Rahman A, Merrill JT, Alarcón GS, Fessler BJ, Fortin PR, Hanly JG, Petri M, Steinsson K, Dooley MA, Manzi S, Khamashta MA, Ramsey-Goldman R, Zoma AA, Sturfelt GK, Nived O, Aranow C, Mackay M, Ramos-Casals M, van Vollenhoven RF, Kalunian KC, Ruiz-Irastorza G, Lim SS, Kamen DL, Peschken CA, Inanc M, Bruce IN.

Ann Rheum Dis. 2015 Aug;74(8):1530-6. doi: 10.1136/annrheumdis-2013-203933. Epub 2014 Apr 1.

29.

Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study.

Hanly JG, Urowitz MB, O'Keeffe AG, Gordon C, Bae SC, Sanchez-Guerrero J, Romero-Diaz J, Clarke AE, Bernatsky S, Wallace DJ, Ginzler EM, Isenberg DA, Rahman A, Merrill JT, Petri M, Fortin PR, Gladman DD, Fessler BJ, Alarcón GS, Bruce IN, Dooley MA, Steinsson K, Khamashta MA, Ramsey-Goldman R, Manzi S, Sturfelt GK, Nived O, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Aranow C, Mackay M, Ruiz-Irastorza G, Kalunian KC, Lim SS, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Theriault C, Thompson K, Farewell V.

Arthritis Rheum. 2013 Nov;65(11):2887-97. doi: 10.1002/art.38106. Erratum in: Arthritis Rheum. 2014 Jun;66(6):1671.

30.

Non-lymphoma hematological malignancies in systemic lupus erythematosus.

Lu M, Bernatsky S, Ramsey-Goldman R, Petri M, Manzi S, Urowitz MB, Gladman D, Fortin PR, Ginzler EM, Yelin E, Bae SC, Wallace DJ, Jacobsen S, Dooley MA, Peschken CA, Alarcón GS, Nived O, Gottesman L, Criswell LA, Sturfelt G, Dreyer L, Lee JL, Clarke AE.

Oncology. 2013;85(4):235-40. doi: 10.1159/000350165. Epub 2013 Oct 2.

31.

The frequency of and associations with hospitalization secondary to lupus flares from the 1000 Faces of Lupus Canadian cohort.

Lee J, Peschken CA, Muangchan C, Silverman E, Pineau C, Smith CD, Arbillaga H, Zummer M, Clarke A, Bernatsky S, Hudson M, Hitchon C, Fortin PR, Pope JE.

Lupus. 2013 Nov;22(13):1341-8. doi: 10.1177/0961203313505689. Epub 2013 Sep 18.

PMID:
24048215
32.

Breast cancer in systemic lupus erythematosus.

Tessier Cloutier B, Clarke AE, Ramsey-Goldman R, Wang Y, Foulkes W, Gordon C, Hansen JE, Yelin E, Urowitz MB, Gladman D, Fortin PR, Wallace DJ, Petri M, Manzi S, Ginzler EM, Labrecque J, Edworthy S, Dooley MA, Senécal JL, Peschken CA, Bae SC, Isenberg D, Rahman A, Ruiz-Irastorza G, Hanly JG, Jacobsen S, Nived O, Witte T, Criswell LA, Barr SG, Dreyer L, Sturfelt G, Bernatsky S.

Oncology. 2013;85(2):117-21. doi: 10.1159/000353138. Epub 2013 Jul 25.

33.

Cancer risk in systemic lupus: an updated international multi-centre cohort study.

Bernatsky S, Ramsey-Goldman R, Labrecque J, Joseph L, Boivin JF, Petri M, Zoma A, Manzi S, Urowitz MB, Gladman D, Fortin PR, Ginzler E, Yelin E, Bae SC, Wallace DJ, Edworthy S, Jacobsen S, Gordon C, Dooley MA, Peschken CA, Hanly JG, Alarcón GS, Nived O, Ruiz-Irastorza G, Isenberg D, Rahman A, Witte T, Aranow C, Kamen DL, Steinsson K, Askanase A, Barr S, Criswell LA, Sturfelt G, Patel NM, Senécal JL, Zummer M, Pope JE, Ensworth S, El-Gabalawy H, McCarthy T, Dreyer L, Sibley J, St Pierre Y, Clarke AE.

J Autoimmun. 2013 May;42:130-5. doi: 10.1016/j.jaut.2012.12.009. Epub 2013 Feb 12.

34.

Association of smoking with cutaneous manifestations in systemic lupus erythematosus.

Bourré-Tessier J, Peschken CA, Bernatsky S, Joseph L, Clarke AE, Fortin PR, Hitchon C, Mittoo S, Smith CD, Zummer M, Pope J, Tucker L, Hudson M, Arbillaga H, Esdaile J, Silverman E, Chédeville G, Huber AM, Belisle P; Canadian Network for Improved Outcomes in Systemic Lupus Erythematosus 1000 Canadian Faces of Lupus Investigators, Pineau CA.

Arthritis Care Res (Hoboken). 2013 Aug;65(8):1275-80. doi: 10.1002/acr.21966.

35.

Lymphoma risk in systemic lupus: effects of disease activity versus treatment.

Bernatsky S, Ramsey-Goldman R, Joseph L, Boivin JF, Costenbader KH, Urowitz MB, Gladman DD, Fortin PR, Nived O, Petri MA, Jacobsen S, Manzi S, Ginzler EM, Isenberg D, Rahman A, Gordon C, Ruiz-Irastorza G, Yelin E, Bae SC, Wallace DJ, Peschken CA, Dooley MA, Edworthy SM, Aranow C, Kamen DL, Romero-Diaz J, Askanase A, Witte T, Barr SG, Criswell LA, Sturfelt GK, Blanco I, Feldman CH, Dreyer L, Patel NM, St Pierre Y, Clarke AE.

Ann Rheum Dis. 2014 Jan;73(1):138-42. doi: 10.1136/annrheumdis-2012-202099. Epub 2013 Jan 8.

36.

Pregnancy and the risk of rheumatoid arthritis in a highly predisposed North American Native population.

Peschken CA, Robinson DB, Hitchon CA, Smolik I, Hart D, Bernstein CN, El-Gabalawy HS.

J Rheumatol. 2012 Dec;39(12):2253-60. doi: 10.3899/jrheum.120269. Epub 2012 Oct 15.

PMID:
23070994
37.

Clinical associations of the metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort.

Parker B, Urowitz MB, Gladman DD, Lunt M, Bae SC, Sanchez-Guerrero J, Romero-Diaz J, Gordon C, Wallace DJ, Clarke AE, Bernatsky S, Ginzler EM, Isenberg DA, Rahman A, Merrill JT, Alarcón GS, Fessler BJ, Fortin PR, Hanly JG, Petri M, Steinsson K, Dooley MA, Manzi S, Khamashta MA, Ramsey-Goldman R, Zoma AA, Sturfelt GK, Nived O, Aranow C, Mackay M, Ramos-Casals M, van Vollenhoven RF, Kalunian KC, Ruiz-Irastorza G, Lim S, Kamen DL, Peschken CA, Inanc M, Bruce IN.

Ann Rheum Dis. 2013 Aug;72(8):1308-14. doi: 10.1136/annrheumdis-2012-202106. Epub 2012 Sep 3. Erratum in: Ann Rheum Dis. 2014 Jan;73(1):320.

38.

Vitamin D receptor polymorphism rs2228570 (Fok1) is associated with rheumatoid arthritis in North American natives.

Hitchon CA, Sun Y, Robinson DB, Peschken CA, Bernstein CN, Siminovitch KA, El-Gabalawy HS.

J Rheumatol. 2012 Sep;39(9):1792-7. doi: 10.3899/jrheum.120387. Epub 2012 Aug 1.

PMID:
22859341
39.

Evaluating systemic lupus erythematosus patients for lung involvement.

Allen D, Fischer A, Bshouty Z, Robinson DB, Peschken CA, Hitchon C, El-Gabalawy H, Meyers M, Mittoo S.

Lupus. 2012 Oct;21(12):1316-25. Epub 2012 Jul 19.

PMID:
22813546
40.

Influence of ethnicity on childhood-onset systemic lupus erythematosus: results from a multiethnic multicenter Canadian cohort.

Levy DM, Peschken CA, Tucker LB, Chédeville G, Huber AM, Pope JE; Canadian Network for Improved Outcomes in SLE 1000 Faces Investigators, Silverman ED.

Arthritis Care Res (Hoboken). 2013 Jan;65(1):152-60. doi: 10.1002/acr.21779.

41.

Prevalence of autoimmune inflammatory myopathy in the first nations population of Alberta, Canada.

Barnabe C, Joseph L, Bélisle P, Labrecque J, Barr SG, Fritzler MJ, Svenson LW, Peschken CA, Hemmelgarn B, Bernatsky S.

Arthritis Care Res (Hoboken). 2012 Nov;64(11):1715-9. doi: 10.1002/acr.21743.

42.

Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study.

Hanly JG, Urowitz MB, Su L, Gordon C, Bae SC, Sanchez-Guerrero J, Romero-Diaz J, Wallace DJ, Clarke AE, Ginzler E, Merrill JT, Isenberg DA, Rahman A, Petri M, Fortin PR, Gladman D, Bruce IN, Steinsson K, Dooley M, Khamashta MA, Alarcón GS, Fessler BJ, Ramsey-Goldman R, Manzi S, Zoma AA, Sturfelt GK, Nived O, Aranow C, Mackay M, Ramos-Casals M, van Vollenhoven R, Kalunian KC, Ruiz-Irastorza G, Lim S, Kamen DL, Peschken CA, Inanc M, Theriault C, Thompson K, Farewell V.

Ann Rheum Dis. 2012 Sep;71(9):1502-9. doi: 10.1136/annrheumdis-2011-201089. Epub 2012 Apr 4.

43.

Familial clustering of the serum cytokine profile in the relatives of rheumatoid arthritis patients.

El-Gabalawy HS, Robinson DB, Smolik I, Hart D, Elias B, Wong K, Peschken CA, Hitchon CA, Li X, Bernstein CN, Newkirk MM, Fritzler MJ.

Arthritis Rheum. 2012 Jun;64(6):1720-9. doi: 10.1002/art.34449. Epub 2012 Feb 21.

44.

Validation of potential classification criteria for systemic sclerosis.

Johnson SR, Fransen J, Khanna D, Baron M, van den Hoogen F, Medsger TA Jr, Peschken CA, Carreira PE, Riemekasten G, Tyndall A, Matucci-Cerinic M, Pope JE.

Arthritis Care Res (Hoboken). 2012 Mar;64(3):358-67. doi: 10.1002/acr.20684.

45.

Rheumatoid arthritis in a north american native population: longitudinal followup and comparison with a white population.

Peschken CA, Hitchon CA, Robinson DB, Smolik I, Barnabe CR, Prematilake S, El-Gabalawy HS.

J Rheumatol. 2010 Aug 1;37(8):1589-95. doi: 10.3899/jrheum.091452. Epub 2010 Jun 15.

PMID:
20551109
46.

Clinical and serologic factors associated with lupus pleuritis.

Mittoo S, Gelber AC, Hitchon CA, Silverman ED, Pope JE, Fortin PR, Pineau C, Smith CD, Arbillaga H, Gladman DD, Urowitz MB, Zummer M, Clarke AE, Bernatsky S, Hudson M, Tucker LB, Petty RE; Canadian Network for Improved Outcomes in Systemic Lupus Erythematosus (CaNIOS), Peschken CA.

J Rheumatol. 2010 Apr;37(4):747-53. doi: 10.3899/jrheum.090249. Epub 2010 Jan 28.

PMID:
20110526
47.

Immunogenetic risks of anti-cyclical citrullinated peptide antibodies in a North American Native population with rheumatoid arthritis and their first-degree relatives.

El-Gabalawy HS, Robinson DB, Hart D, Elias B, Markland J, Peschken CA, Smolik I, Montes-Aldana G, Schroeder M, Fritzler MJ, Cheang M, Oen K.

J Rheumatol. 2009 Jun;36(6):1130-5. doi: 10.3899/jrheum.080855. Epub 2009 May 1.

PMID:
19411392
48.

The 1000 Canadian faces of lupus: determinants of disease outcome in a large multiethnic cohort.

Peschken CA, Katz SJ, Silverman E, Pope JE, Fortin PR, Pineau C, Smith CD, Arbillaga HO, Gladman DD, Urowitz M, Zummer M, Clarke A, Bernatsky S, Hudson M; Canadian Network for Improved Outcomes in Systemic Lupus Erythematosus (CaNIOS).

J Rheumatol. 2009 Jun;36(6):1200-8. doi: 10.3899/jrheum.080912. Epub 2009 Apr 15.

PMID:
19369456
49.

Marked differences in fine specificity and isotype usage of the anti-citrullinated protein antibody in health and disease.

Ioan-Facsinay A, Willemze A, Robinson DB, Peschken CA, Markland J, van der Woude D, Elias B, Ménard HA, Newkirk M, Fritzler MJ, Toes RE, Huizinga TW, El-Gabalawy HS.

Arthritis Rheum. 2008 Oct;58(10):3000-8. doi: 10.1002/art.23763.

50.

Sm antibodies increase risk of death in systemic lupus erythematosus.

Hitchon CA, Peschken CA.

Lupus. 2007;16(3):186-94.

PMID:
17432104

Supplemental Content

Loading ...
Support Center